Deniz Kirik
71 – 80 of 174
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
GDNF fails to exert neuroprotection in a rat {alpha}-synuclein model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits.
(
- Contribution to journal › Article
-
Mark
Magnetic Resonance Spectroscopic Methods for the Assessment of Metabolic Functions in the Diseased Brain.
2011) In Current Topics in Behavioral Neurosciences(
- Contribution to journal › Article
-
Mark
Efficacy of L-DOPA therapy in Parkinson's disease
2011) p.454-463(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2010
-
Mark
Feasibility of in vivo N-15 MRS detection of hyperpolarized N-15 labeled choline in rats
(
- Contribution to journal › Article
-
Mark
CELL THERAPY FOR PARKINSON'S DISEASE: PERSPECTIVES ON THE CLINICAL EXPERIENCE
2010) 10th Biennial Meeting of the Asia-Pacific Society of Neurochemistry In Journal of Neurochemistry 115(Suppl. 1). p.2-2(
- Contribution to journal › Published meeting abstract
-
Mark
Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Microglia Acquire Distinct Activation Profiles Depending on the Degree of alpha-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Gene Therapy
(
- Contribution to journal › Published meeting abstract
-
Mark
Glial Cell Derived Neurotrophic Factor Does not Provide Neuroprotection Against Alpha-Synuclein-Induced Toxicity in a Rat Model of Parkinson's Disease
(
- Contribution to journal › Published meeting abstract